Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-01-05 @ 10:30 PM
Study NCT ID:
NCT00114218
Status:
COMPLETED
Last Update Posted:
2019-01-08
First Post:
2005-06-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
Sponsor:
Gynecologic Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-03
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-06-13
First Submit QC Date:
None
Study First Post Date:
2005-06-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-14
Results First Submit QC Date:
None
Results First Post Date:
2018-10-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-17
Last Update Post Date:
2019-01-08
Last Update Post Date Type:
ACTUAL